These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10746590)

  • 1. MS functional composite: relation to disease phenotype and disability strata.
    Kalkers NF; de Groot V; Lazeron RH; Killestein J; Adèr HJ; Barkhof F; Lankhorst GJ; Polman CH
    Neurology; 2000 Mar; 54(6):1233-9. PubMed ID: 10746590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent validity of the MS Functional Composite using MRI as a biological disease marker.
    Kalkers NF; Bergers L; de Groot V; Lazeron RH; van Walderveen MA; Uitdehaag BM; Polman CH; Barkhof F
    Neurology; 2001 Jan; 56(2):215-9. PubMed ID: 11160958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S; Cagiran I; Ormeci B; Idiman E
    J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].
    Mezei Z; Bereczki D; Csiba L; Csépány T
    Ideggyogy Sz; 2006 Nov; 59(11-12):442-7. PubMed ID: 17203882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study validating changes in the multiple sclerosis functional composite.
    Hoogervorst EL; Kalkers NF; Uitdehaag BM; Polman CH
    Arch Neurol; 2002 Jan; 59(1):113-6. PubMed ID: 11790238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
    Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of patient self-report, neurologic examination, and functional impairment in MS.
    Hoogervorst EL; van Winsen LM; Eikelenboom MJ; Kalkers NF; Uitdehaag BM; Polman CH
    Neurology; 2001 Apr; 56(7):934-7. PubMed ID: 11294932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of the Multiple Sclerosis Functional Composite in Debrecen].
    Mezei Z; Bereczki D; Csiba L; Csépány T
    Ideggyogy Sz; 2005 Mar; 58(3-4):113-8. PubMed ID: 15887414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses.
    Bin Sawad A; Seoane-Vazquez E; Rodriguez-Monguio R; Turkistani F
    Curr Med Res Opin; 2016 Dec; 32(12):1969-1974. PubMed ID: 27603119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The multiple sclerosis functional composite: a clinically meaningful measure of disability.
    Polman CH; Rudick RA
    Neurology; 2010 Apr; 74 Suppl 3():S8-15. PubMed ID: 20421572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.
    Baier ML; Cutter GR; Rudick RA; Miller D; Cohen JA; Weinstock-Guttman B; Mass M; Balcer LJ
    Neurology; 2005 Mar; 64(6):992-5. PubMed ID: 15781814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
    Kragt JJ; Thompson AJ; Montalban X; Tintoré M; Río J; Polman CH; Uitdehaag BM
    Neurology; 2008 Mar; 70(13 Pt 2):1084-91. PubMed ID: 18184917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life.
    Miller DM; Rudick RA; Cutter G; Baier M; Fischer JS
    Arch Neurol; 2000 Sep; 57(9):1319-24. PubMed ID: 10987899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multiple sclerosis functional composite: a new clinical outcome measure for multiple sderosis trials.
    Rudick RA; Cutter G; Reingold S
    Mult Scler; 2002 Oct; 8(5):359-65. PubMed ID: 12356200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.
    Hobart J; Kalkers N; Barkhof F; Uitdehaag B; Polman C; Thompson A
    Mult Scler; 2004 Feb; 10(1):41-6. PubMed ID: 14760951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing disability progression with the Multiple Sclerosis Functional Composite.
    Rudick RA; Polman CH; Cohen JA; Walton MK; Miller AE; Confavreux C; Lublin FD; Hutchinson M; O'Connor PW; Schwid SR; Balcer LJ; Lynn F; Panzara MA; Sandrock AW
    Mult Scler; 2009 Aug; 15(8):984-97. PubMed ID: 19667023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS.
    Rudick RA; Cutter G; Baier M; Fisher E; Dougherty D; Weinstock-Guttman B; Mass MK; Miller D; Simonian NA
    Neurology; 2001 May; 56(10):1324-30. PubMed ID: 11376182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
    Brochet B; Deloire MS; Bonnet M; Salort-Campana E; Ouallet JC; Petry KG; Dousset V
    Mult Scler; 2008 Nov; 14(9):1242-9. PubMed ID: 18653737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis.
    Patzold T; Schwengelbeck M; Ossege LM; Malin JP; Sindern E
    Acta Neurol Scand; 2002 Mar; 105(3):164-8. PubMed ID: 11886358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.